Growing evidence has shown that numerous cancer types, including liver, lung, ovarian, breast, colon, and gastric cancer, as well as multiple myeloma, manifest increased SOCE and augmented expression of STIM1 or Orai1. This evidence concerns the gene STIM1 and plasma cell myeloma.